bosentan anhydrous has been researched along with Blood Poisoning in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goraca, A; Kleniewska, P; Kolodziejczyk, M; Kowalczyk, A; Skibska, B | 1 |
Brookes, ZL; Brown, NJ; Mansart, A; Reilly, CS; Ross, JJ | 1 |
Fischer, SR; Traber, DL | 1 |
1 review(s) available for bosentan anhydrous and Blood Poisoning
Article | Year |
---|---|
The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis.
Topics: Animals; Bosentan; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Humans; Inflammation; Lipopolysaccharides; NF-kappa B; Oligopeptides; Peptides, Cyclic; Piperidines; Pyridines; Reactive Oxygen Species; Sepsis; Signal Transduction; Sulfonamides; Superoxides; Tetrazoles | 2015 |
2 other study(ies) available for bosentan anhydrous and Blood Poisoning
Article | Year |
---|---|
LPS abolishes extrasplenic vasoconstriction to atrial natriuretic peptide: the role of NO and endothelin 1.
Topics: Animals; Antihypertensive Agents; Arteries; Atrial Natriuretic Factor; Blood Volume; Bosentan; Endothelin-1; Enzyme Inhibitors; Hypovolemia; Lipopolysaccharides; Male; Mesentery; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Penicillamine; Rats; Rats, Wistar; Sepsis; Spleen; Sulfonamides; Vascular Resistance; Vasoconstriction; Veins | 2008 |
L-arginine and endothelin receptor antagonist bosentan counteract hemodynamic effects of modified hemoglobin.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Substitutes; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Female; Hemodynamics; Hemoglobins; Nitric Oxide; Polyethylene Glycols; Sepsis; Sheep; Sulfonamides; Vasoconstriction | 1999 |